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Abstract:  
Urologic and gynecologic surgeons are the top utilizers of robotic surgery; however, 
non-obstetrical robotic-assisted laparoscopic surgery (RALS) in pregnant patients is infrequent. 
A systematic literature review was performed to ascertain the frequency, indication and 
complications of RALS in pregnancy. Results showed thirty-eight pregnancies from eleven 
publications between 2008-2020. Five cases were for urologic indication and thirty-three for 
gynecologic indication. Minimal surgical alterations were required.  Although no adverse 
maternal-fetal outcomes were reported, there are not enough cases published to determine 
safety. This review demonstrates the feasibility of RALS for the pregnant population in the 
hands of competent robotic surgeons. 
 
Introduction: 
 The use of robotic-assisted laparoscopic surgery (RALS) has become a mainstay of many 
surgical specialties. As more specialties have adopted its use and surgeons began to expand its 
reach, RALS has become a common option for many patients for various indications, including 
intraperitoneal, retroperitoneal, thoracic, and pelvic procedures.  Currently, urological and 
         
gynecologic surgeons utilize RALS at the highest frequency and for a wide breadth of 
indications.1 Uniquely, these specialties’ pelvic procedures adapt well to robotic surgery, as it 
facilitates visualization and manipulation within a confined space. Despite its common use by 
gynecologists, the incorporation of RALS into the care of pregnant patients is rare. Historically, 
there have been concerns that the unique parameters necessitated by laparoscopic surgery 
were incompatible with the physiologic changes in pregnancy.  Laparoscopy has since been 
deemed relatively safe,2 with modest adjustments to compensate for the gravid physiology and 
anatomy, yet the robotic iteration of this technique lags behind.  One in 500 women require 
non-obstetrical intraperitoneal surgery during pregnancy; 64.8% of these surgical interventions 
are performed laparoscopically.3 Herein, a systematic literature review was performed in order 
to quantify the application of RALS in pregnant patients, catalogue the types of indications for 




We conducted a search using Ovid MEDLINE, PubMed, and Scopus from 2000 to January 
21, 2020 as the da Vinci surgical system was approved around 2000 by the Food and Drug 
Administration. Relevant papers addressing robotic surgery in pregnancy were identified. No 
limitations were made based on study design or language. We adopted the following search 
terms: (pregnancy  OR  antepartum  OR  pregnan* OR  matern*  OR  obstetric* )  AND  ( ( 
robotic  AND surgical  AND procedures )  OR  ( robotic  AND surgery )  OR  ( ( robot*  OR  ( ( ( 
         
robot-assisted )  OR  ( robotic-assisted ) )  AND  laparoscop* ) )  AND  ( ( minimally  AND 
invasive  AND surgery )  OR  ( minimally  AND invasive  AND surgical  AND procedures ) ) )  OR  ( 
robot-assisted  AND surgery ) )  OR  ( "da vinci"  OR  davinci ) ) ). The systematic review followed 
the Preferred Reporting Items of Systematic Reviews and Meta-analysis (PRISMA) guidelines.4 
See appendix for the full search strategies.  
 The search yielded 1298 articles. Eligibility of the studies was independently reviewed 
by two authors (C.C. and J.G.). Studies were included that addressed non-obstetric 
transabdominal robotic surgery occurring during pregnancy. Studies including robotic cerclage 
placement, robotic fetoscopic surgery, robotic surgery for ectopic pregnancy, robotic surgery 
postpartum and studies without detailed clinical data were excluded. Disagreements were 
resolved by deliberation with a third reviewer (H.A.K). The reference lists of all included studies 
were examined to help identify studies not captured by the initial search. A total of 11 studies 




Thirty-eight patients who underwent RALS during pregnancy met the inclusion criteria in 
eleven publications (Table 1).  The mean maternal age was 30.0 + 6.3 years with 75% 
multiparous (n=27) and 25% primiparous (n=9). All of the RALS occurred in the second trimester 
with a mean gestational age of 18.7 weeks (range: 14-23) (Table 1). Mode of entry into the 
         
abdomen was reported in 8 of the 11 publications. Three reported using Veress needle, 3 using 
direct entry, and 2 Hasson technique (Table 2).  Seven of the 11 publications (63.6%) endorsed 
maintaining a pneumoperitoneum less than or equal to 12mmHg. Estimated blood loss  (EBL) 
ranged from 0 cc to 350cc. EBL was < 50 cc for 83.3% (30/36), 51 to 200 cc for 13.8% (5/36), and 
> 200 cc for 2.7% (1/36) of patients.  Mean surgical duration was 104 minutes (range: 60-270). 
Discharge from the hospital was on or before postoperative day (POD) 1 for 89% of patients 
(25/28) with only 11% (3/28) discharged beyond POD 1 (range: POD4-POD6). No intraoperative 
maternal or fetal complications were recorded during any of the surgeries (Table 1).  
The indication for RALS was ovarian in 33 (87%) and urologic in 5 (13%). The types of 
RALS performed for the ovarian category were as follows: ovarian cystectomy (n=25, 76.4%), 
oophorectomy (n=5, 14.7%), salpingo-oophorectomy (n=3, 8.8%). One patient received both 
left salpingo-oophorectomy and right partial ovarian cystectomy. Of these cases, 3 performed 
an omentectomy (9.1%), 2 performed pelvic washings (6.1%), and 1 performed a bilateral pelvic 
lymph node dissection (3.0%). Additionally, one publication had a series of nineteen cases and 
the data was reported in aggregate; they did not report standard deviation for gestational age 
at surgery and surgical duration, so these standard deviations could not be calculated in our 
review.5   The types of RALS performed for the urologic category included adrenalectomy (n=3, 
60.0%) and partial nephrectomy (n=2, 40%). The indications for the adrenalectomies were 
pheochromocytoma (n=1), Cushing syndrome (n=1), and subclinical Cushing syndrome (n=1).   
The recorded postoperative surgical complications were one postoperative pneumonia 
requiring readmission and antibiotics, and one patient complaining of pain at the trocar sites at 
         
2 weeks postoperatively.  Six of the thirty-eight patients (15.7%) had malignant pathology and 
one underwent chemotherapy during pregnancy.6  
Obstetrical outcomes were reported for a limited number of cases. Eight patients had a 
vaginal delivery and 4 had cesarean delivery with 2 of them being scheduled (1 for cancer 
biopsies at time of cesarean section and 1 for unspecified indication).  The mean gestational 
age at delivery was 38.3 weeks, with only 2 patients delivering < 37 weeks. Neonatal outcomes 
were reported for a limited number of cases (n=11), and all had a healthy neonate at delivery. 
There was one case of preterm premature rupture of membranes at 30 weeks for which the 




Approximately 1 in 500 women will require non-obstetrical abdominal surgery during 
their pregnancy, most commonly for appendicitis, cholecystitis and small bowel obstruction. 7-9 
The most common gynecologic indication is adnexal masses, which occur at a rate between 
1/81 and 1/6000 pregnancies.10 Persistent masses pose a clinical challenge on whether to 
observe or intervene, but literature shows between 2% and 6% of these masses are 
malignant.10 Management of ovarian masses is operative based on persistence, size and 
ultrasound characteristics.11 Urologically, pheochromocytoma occurs in 1 in 50,000 
         
pregnancies, and renal cell carcinoma in women of child bearing age occur < 5/100,000 cases 
per year.12,13  
Since its inception, robotic surgery has been rapidly incorporated into the repertoires of 
surgeons across the nation since its approval. Although results vary depending on the surgery 
type, evidence often shows shortened duration of hospital stay, lower conversion rates, and 
lower blood loss.14-16 The three-dimensional visualization and dynamic articulation seem well 
suited for performing surgery while sharing the abdomen with a gravid uterus. Our systematic 
review demonstrates low implementation of robotic surgery for non-obstetrical indications in 
pregnant patients, with only thirty-eight cases in the last twenty years, and nineteen of those 
cases representing a single institution experience.  Even rarer were urological indications, 
representing only 5 of the thirty-eight cases within the literature. 
It is not unprecedented for newer techniques to lag behind when it comes to their 
application in the pregnant patient populations. In fact, laparoscopic surgery itself was 
suspected to be a contraindication in pregnancy in general. It was hypothesized that the 
pneumoperitoneum necessary for laparoscopy would endanger both the mother and fetus. 
Specifically, the carbon dioxide exposure was thought to be harmful to the developing fetus. 
For the pregnant patient, there were concerns that the increased intraabdominal pressure from 
the pneumoperitoneum would compress the inferior vena cava (IVC), dampen venous return, 
and cause insufficient ventilation due to the intraabdominal pressure exerted on the 
diaphragm.17,18  However, it has since been shown that laparoscopic surgery does not entail 
additional risk, and was superior in length of stay, diet advancement, and narcotic use.2  The 
         
use of the robot builds on the advantages of laparoscopy while not demanding any additional 
parameters that could pose risk to patient or fetus. Specifically, its superior visualization, 
ergonomic movements, tremor filtration, and multiple degree articulations may prove useful 
while navigating a gravid uterus using a reduced intraabdominal pressure.  In fact, in non-
pregnant patients, RALS has been shown to have similar operative time and conversion rates 
when compared to traditional laparoscopy for adrenal surgeries.14,19  
Robotic-assisted obstetrical cases, specifically cerclage placement and resection of 
ectopic pregnancies, were excluded from our systematic review. Recently, a large systematic 
review with sixty-four patients undergoing robotic cerclages was already published.20 
Additionally, because cerclage is performed on the uterus itself, it does not impose the same 
unique parameters that are faced when the target of a procedure is elsewhere within the 
abdominal cavity. Our rational for excluding ectopic pregnancies was due to the fact that the 
fetus is not viable, and such cases do not share the unique challenges of the other 
intraabdominal gestational RALS cases; such obstacles include manipulation around the gravid 
uterus and prioritizing fetal viability. Additionally, multiple ectopic cases managed robotically 
reported in the literature occur in the first trimester.21-23 These cases do not entail the same 
parameters of fetal risk, uteroplacental blood flow, and anesthesia implications.  
Despite the paucity of cases within the literature for non-obstetrical RALS, there were 
commonalities between them. All surgeries were performed within the second trimester.  This is 
expected, as the second trimester is following the completion of organogenesis within the first 
trimester and is before the third trimester wherein the gravid uterus presents a cumbersome 
         
surgical obstacle.2,24,25 Blood loss was also consistently low with 83.3% having an EBL <50. This 
is in line with other literature often demonstrating lower EBL as a benefit of RALS.1,14,16 Also 
consistent with purported benefits of RALS, postoperative stay was generally short, with only 3 
(11%) patients enduring hospitalization beyond POD day 1. Of note, all three of these cases had 
a urologic indication: partial nephrectomy (n=2) and pheochromocytoma (n=1). Therefore, the 
longer hospital stay in those cases may be due to the intrinsic nature of the operation and need 
for post-operative monitoring rather than post-operative recovery.  
Additionally, with regard to patient positioning, we acknowledge that there is little room 
for adjustment, as many surgeries require predetermined patient position. In pregnant 
patients, the gravid uterus places pressure on the IVC, impeding venous return and impact ing 
fetal blood flow.26,27 Besides obvious anesthetic implications, positioning patients in supine can 
worsen the hypotension and disrupt placental blood flow. Therefore, favoring positions such as 
left lateral tilt and avoiding a full supine position can reduce the risk of adverse hemodynamic 
changes.12,28,29 As many urologic and gynecologic procedures require Trendelenburg 
positioning, this may be beneficial for both the patient and the fetus. However, in certain cases, 
such as a left sided partial nephrectomy, the surgical team may have no choice but to posi tion 
the patient on the right side. 30 When feasible, modifications such as left lateral decubitus 
should be implemented to limit IVC compression and improve maternal cardiac output.29,31 
A modification utilized specifically in 2 of the reported cases was the use of the open-
entry Hasson technique for entry into the peritoneum, in lieu of closed-entry Veress access. 
Three authors utilized a direct vision entry into the abdomen to ensure atraumatic entry. 
         
Specifically, Eichelberger et al., Mendevil et al., and Podolsky et al. used 2-mm trocar and 2-mm 
laparoscope, 5-mm laparoscope, and 12-mm trocar, respectively.5,12,32  Under typical 
conditions, there is no significant difference in major complication rates between these 
techniques and mode of entry is typically determined by surgeon preference .33-36 However, in 
the setting of pregnancy, there was concern in some studies that the Veress needle could injure 
the uterus on penetration, as it is a blind approach to gaining abdominal access. Yet, as seen in 
several of the reported studies, Veress access was successful without any major complications. 
Therefore, we conclude that all modes of peritoneal access are acceptable, so long as there is 
proper compensation for the size of the gravid uterus. If entry is obtained in the upper 
abdomen, above the level of the gravid uterus, then the risk of injury to the uterus is minimized 
and surgeon preference should dictate technique. However, if the entry is planned in the lower 
abdomen, consideration should be given to an open-entry technique despite a lack of evidence 
to support its absolute necessity.  
With regard to port placement and intra-operative technique, additional modifications 
may be required. In the majority of the cases identified in this review, there were no significant 
modifications to port placement (Table 2). In the few cases where modifications were 
specifically commented on, the inferior ports were shifted slightly cephalad to ensure safe port 
placement.13,37 However, per standard guidelines, all ports in all studies were placed under 
direct vision – and the cephalad ports were placed first to ensure adequate visualization. Of 
note, there were no major intra-operative modifications to technique for the urologic cases; for 
the gynecologic cases, there were slight modifications worth noting. First, and somewhat 
obvious, a uterine manipulator is contraindicated in these cases. In order to displace the uterus 
         
for better visualization, Al-Badawi et al. utilized a 10-mm dismantling fan retractor for traction 
as it was believed this would be the most atraumatic instrument for safely applying some 
traction on the gravid uterus. In contrast, Chen et al. utilized a grasper via the accessory port to 
lift and hold the round ligament to create enough working space. None of the other series 
noted specific modifications to account for the gravid uterus.  
Due to the nature of systematic reviews, the findings herein are subject to potential 
publication bias. It may be that RALS surgeries in pregnancy have been performed but have 
simply not been reported in the literature. Considering RALS is sometimes performed over 
traditional laparoscopic surgery secondary to surgeon preference, underreporting may occur 
due to surgeons not considering this procedure novel, but rather a technique interchangeable 
with laparoscopy. This could lead to unreported outcomes, complications and surgical 
modifications that are not accounted for in our review. Additionally, the studies included lack 
substantial and uniform outcome data, such as the Clavien-Dindo classification38. While overall 
safety cannot be established, no cases in this review showed significant post-operative 
complications or maternal-fetal complications.  
Perhaps owing to the paucity of cases, no current guidelines exist in regard to RALS 
within this population. Although commonalities clearly exist, the lack of standards is made 
apparent by the variation in surgical modifications exhibited by the cases in our review. Our 
review is of particular importance due to the fact that robotic urologic surgeries now exceed 
laparoscopic surgeries in terms of volume.1 As robotics become a larger part of the field of 
urology, a larger number of urology trainees will be increasingly comfortable with robotic 
         
surgery rather than laparoscopic procedures. This will continue the trend toward robotics, as it 
has been established that surgeons trained in certain procedures are more likely to perform 
these procedures in their future practice.39 As RALS becomes the de facto intervention due to 
surgeon’s preference, it is important to validate its implementation in the pregnant populat ion. 
Switching to a laparoscopic approach for the sole indication of pregnancy may present 
suboptimal conditions if the physician is more comfortable with a robotic approach. Our results 





Our review demonstrates the rarity of RALS in pregnant patients for non-obstetrical 
indications. Based on the published literature, our review demonstrates that RALS could be a 
safe and effective in pregnancy. However, in order to conclusively evaluate the safety, 
superiority, or inferiority of non-obstetric RALS versus traditional laparoscopic surgery in the 
pregnant population, further studies are necessary.  As robotic surgery becomes more 
ubiquitous within urologic and gynecologic training, RALS may be implemented on the basis of 
surgeon preference and comfort. Therefore, we encourage tertiary care centers performing 
non-obstetrical RALS to publish their pregnancy outcomes and complication rate s in order to 
build an evidence-base to guide future practice. 
         
 
 































1. McGuinness LA, Prasad Rai B. Robotics in urology. Ann R Coll Surg Engl. 
2018;100(6_sup):38-44. 
2. Curet MJ, Allen D, Josloff RK, et al. Laparoscopy during pregnancy. Arch Surg. 
1996;131(5):546-550; discussion 550-541. 
3. Erekson EA, Brousseau EC, Dick-Biascoechea MA, et al. Maternal postoperative 
complications after nonobstetric antenatal surgery. J Matern Fetal Neonatal Med. 
2012;25(12):2639-2644. 
4. Mohler D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses: The PRISMA Statement. PLOS Medicine. 2019;6(7):e1000097. 
5. Eichelberger KY, Cantrell LA, Balthazar U, et al. Robotic resection of adnexal masses 
during pregnancy. American Journal of Perinatology. 2013;30(5):371-375. 
6. Chen CH, Chiu LH, Chan C, et al. Management of ovarian cancer in 14th gestational 
week of pregnancy by robotic approach with preservation of the fetus. Gynecol Obstet 
Invest. 2015;80(2):139-144. 
         
7. Kammerer WS. Nonobstetric surgery during pregnancy. Med Clin North Am. 
1979;63(6):1157-1164. 
8. Kort B, Katz VL, Watson WJ. The effect of nonobstetric operation during pregnancy. 
Surg Gynecol Obstet. 1993;177(4):371-376. 
9. Augustin G, Majerovic M. Non-obstetrical acute abdomen during pregnancy. Eur J 
Obstet Gynecol Reprod Biol. 2007;131(1):4-12. 
10. Carter S, Depasquale S, Stallings S. Robotic-Assisted Laparoscopic Ovarian 
Cystectomy during Pregnancy. AJP Rep. 2011;1(1):21-24. 
11. Naqvi M, Kaimal A. Adnexal masses in pregnancy. Clin Obstet Gynecol. 2015;58(1):93-
101. 
12. Podolsky ER, Feo L, Brooks AD, et al. Robotic resection of pheochromocytoma in the 
second trimester of pregnancy. Journal of the Society of Laparoendoscopic Surgeons. 
2010;14(2):303-308. 
13. Ramirez D, Maurice MJ, Seager C, et al. Robotic Partial Nephrectomy During 
Pregnancy: Case Report and Special Considerations. Urology. 2016;92:1-5. 
14. Brandao LF, Autorino R, Laydner H, et al. Robotic versus laparoscopic adrenalectomy: a 
systematic review and meta-analysis. Eur Urol. 2014;65(6):1154-1161. 
15. Kulaylat AS, Mirkin KA, Puleo FJ, et al. Robotic versus standard laparoscopic elective 
colectomy: where are the benefits? J Surg Res. 2018;224:72-78. 
16. Tan A, Ashrafian H, Scott AJ, et al. Robotic surgery: disruptive innovation or unfulfilled 
promise? A systematic review and meta-analysis of the first 30 years. Surg Endosc. 
2016;30(10):4330-4352. 
17. Gadacz TR, Talamini MA. Traditional versus laparoscopic cholecystectomy. Am J Surg. 
1991;161(3):336-338. 
18. Soper NJ, Stockmann PT, Dunnegan DL, et al. Laparoscopic cholecystectomy. The new 
'gold standard'? Arch Surg. 1992;127(8):917-921; discussion 921-913. 
         
19. Brunaud L, Bresler L, Ayav A, et al. Robotic-assisted adrenalectomy: what advantages 
compared to lateral transperitoneal laparoscopic adrenalectomy? Am J Surg. 
2008;195(4):433-438. 
20. Iavazzo C, Minis EE, Gkegkes ID. Robotic assisted laparoscopic cerclage: A systematic 
review. Int J Med Robot. 2019;15(1):e1966. 
21. Persson J, Reynisson P, Masback A, et al. Histopathology indicates lymphatic spread of 
a pelvic retroperitoneal ectopic pregnancy removed by robot-assisted laparoscopy with 
temporary occlusion of the blood supply. Acta Obstet Gynecol Scand. 2010;89(6):835-
839. 
22. Park JH, Cho S, Choi YS, et al. Robot-assisted segmental resection of tubal pregnancy 
followed by end-to-end reanastomosis for preserving tubal patency and fertility: An initial 
report. Medicine (Baltimore). 2016;95(41):e4714. 
23. Ansari A, Ahmad S, James JA, et al. Robotic-assisted laparoscopic resection of cornual 
ectopic pregnancy. A case report. J Reprod Med. 2015;60(1-2):58-64. 
24. Eschler DC, Kogekar N, Pessah-Pollack R. Management of adrenal tumors in 
pregnancy. Endocrinol Metab Clin North Am. 2015;44(2):381-397. 
25. Comitalo JB, Lynch D. Laparoscopic cholecystectomy in the pregnant patient. Surg 
Laparosc Endosc. 1994;4(4):268-271. 
26. Warland J. Back to basics: avoiding the supine position in pregnancy. J Physiol. 
2017;595(4):1017-1018. 
27. Pearl J, Price R, Richardson W, et al. Guidelines for diagnosis, treatment, and use of 
laparoscopy for surgical problems during pregnancy. Surg Endosc. 2011;25(11):3479-
3492. 
28. Pearl JP, Price RR, Tonkin AE, et al. SAGES guidelines for the use of laparoscopy 
during pregnancy. Surg Endosc. 2017;31(10):3767-3782. 
         
29. Creasy RK, Resnik R, Iams JD. Creasy and Resnik's maternal-fetal medicine : principles 
and practice. 6th ed. Philadelphia, PA: Saunders/Elsevier; 2009. 
30. Park SY, Ham WS, Jung HJ, et al. Robot-assisted laparoscopic partial nephrectomy 
during pregnancy. Journal of Robotic Surgery. 2008;2(3):193-195. 
31. Andreoli M, Servakov M, Meyers P, et al. Laparoscopic surgery during pregnancy. J Am 
Assoc Gynecol Laparosc. 1999;6(2):229-233. 
32. Mendivil AA, Brown JV, 3rd, Abaid LN, et al. Robotic-assisted surgery for the treatment 
of pelvic masses in pregnant patients: a series of four cases and literature review. 
Journal of Robotic Surgery. 2013;7(4):333-337. 
33. Ahmad G, Gent D, Henderson D, et al. Laparoscopic entry techniques. Cochrane 
Database Syst Rev. 2015;8:CD006583. 
34. Vilos GA, Ternamian A, Dempster J, et al. No. 193-Laparoscopic Entry: A Review of 
Techniques, Technologies, and Complications. J Obstet Gynaecol Can. 2017;39(7):e69-
e84. 
35. Cornette B, Berrevoet F. Trocar Injuries in Laparoscopy: Techniques, Tools, and Means 
for Prevention. A Systematic Review of the Literature. World J Surg. 2016;40(10):2331-
2341. 
36. Dunne N, Booth MI, Dehn TC. Establishing pneumoperitoneum: Verres or Hasson? The 
debate continues. Ann R Coll Surg Engl. 2011;93(1):22-24. 
37. Capella C, Chandrasekar, T., Counsilman, MJ., Lallas, C.D., Al-Kouatly, H.B. . Robotic 
adrenalectomy for functional adenoma in second trimester treats worsening 
hypertension. In. Urology, Submitted.2020. 
38. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical 
complications: five-year experience. Ann Surg. 2009;250(2):187-196. 
39. Shay BF, Thomas R, Monga M. Urology practice patterns after residency training in 
laparoscopy. J Endourol. 2002;16(4):251-256. 





         
Table 1. Clinical and surgical information of non-obstetrical RALS in pregnancy 


















































healthy neonate, birth 
weight 3200 g; CT scan 
2 months postpartum 
showed no  evidence of 
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Vaginal delivery at 
term, healthy neonate, 
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Apgar score 9’-9’ 
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Painful 18 cm left 
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Cesarean delivery at 37 
wks for cancer staging, 
healthy neonate, birth 
weight 2888 g; Apgar 
score 9’-9’; CT scan at 
18 months postpartum 
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mean diameter of 
















Mean gestational age at 
delivery 38.6 wks with 
one preterm at <37 
wks; mean birth weight 















































Vaginal delivery at 37 
wks, healthy neonate, 
birth weight 2892 g; 
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endometrio
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Vaginal delivery at 39 
wks, healthy neonate, 
birth weight 3024 g; 
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hemorrhagi
Vaginal delivery at 38 
wks, healthy neonate, 
birth weight 2956 g; 































Vaginal delivery at 39 
wks, healthy neonate, 
birth weight 3030 g; 
































Cesarean delivery for 
failure to progress at 39 
wks, healthy neonate, 
birth weight 2800 g; 
Apgar 8-9, POD3 pre-
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Scheduled cesarean 
delivery at 36 wks, 
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steroid therapy  
NR  cal 
adenoma 
healthy neonate, birth 
weight 2550 g; normal 
Apgar; ACTH normal at 



































































Cesarean delivery after 
failed induction for 
oligohydramnios at 39 
wks, healthy neonate; 
blood pressure stable at 
one month postpartum 
         





























Vaginal delivery at 














































 Vaginal delivery: n=8 
Cesarean: n=4 
NR=26 
         
=1 
         
Abbreviations: GA, gestational age, NR, not reported, POD, post-op day, PPROM, preterm premature rupture of 
membranes, PLND, pelvic lymph node dissection, QID, four times a day, RCC, renal cell carcinoma, TID, three times a 
day, wks, weeks  
aData was reported in aggregate (n=19) 
bOnly 8 of the 19 subjects had maternal-fetal information available 
cStandard deviation could not be calculated because Eichelberger et al. reported their data as aggregate with 19 patients. 
They did not report standard deviation for GA at surgery and surgical duration  
 
 
Table 2. Surgical Modifications for non-obstetrical RALS in pregnancy 
Author Anesthesia Access Port Placement Positioning Pneumo-
peritoneum 
Other 











NR - One 12-mm assistant 
port placed at the left 
upper quadrant (Palmer’s 
point) 
- Three robotic port sites 
placed under direct vision 
with an endoscopic 
camera through the 
assistant port 
NR Limited to 
12 mmHg  
Utilized a 10-mm 
dismantling fan 
retractor for 












lithotomy with a 
right lateral tilt 
allowing easier 





12 mmHg  
- Nasogastric 
tube inserted into 
the stomach 
- No instruments 
applied to the 






NR NR Limited to 
12 mmHg  
NR 
         
Chen  
2015 
NR NR - Trocar setting at a higher 
position suggested for 
cases with large uterus or 
pregnancy >13 weeks 
- Adopting sites 6 cm 
above the umbilicus for 
the scope, & 8–10 cm 
caudal-lateral to the scope 
for the side arms  
NR NR - No uterine 
manipulator used 
- Tocolytic agents 
given before, 
throughout & after 
the surgery 
- Utilized a 
grasper via the 
accessory port to 
lift & hold the 










Midline 12-mm trocar 
placed sufficiently above 
the fundus followed by 2- 
to 8-mm trocars placed at 
10 cm to the right & left of 
the midline trocar 
NR NR NR 
Mendivil 
2013 





NR NR NR NR 





Mild cephalad deviation  NR Limited to 









NR NR Limited to 








First trocar placed in the 
left upper quadrant or 





















12 mmHg  
 
Avoided the use 
of mannitol 
 
         






         
